Finished
Cold Plasma for the Reduction of Lymphoceles Following PLND
NCT02658851 · Apyx Medical · Updated 2 Dec 2020
- What is being tested
- J-Plasma
- For
- Lymphoceles Following Pelvic Lymph Node Dissection
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 100 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started June 2016, ends 27 June 2017. Registered 20 Jan 2016.
- Results
- Posted on the registry on 2 Dec 2020.
In the researchers' words
This study protocol will evaluate the efficacy of Bovie Medical's J-Plasma® helium based plasma technology in the reduction of lymphoceles following pelvic lymph node dissection (PLND) during robotic assisted radical prostatectomy (RARP). The J-Plasma® handpiece will be used during the PLND by dissecting the lymph nodes and sealing the lymphatic channels to prevent lymph leakage.
Sites
- Florida Hospital Global Robotics InstituteCelebration, Florida, United States
